Dual response of calpain to rat brain postdecapitative ischemia

Molecular and Chemical Neuropathology

Volumn 33, Issue 3, 1998, Pages 185-197

  Zalewska, T ^a   Zablocka B ^a   Saido, T C ^a   Zajac H ^a   Domanska Janik K ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Ca2+ dependent proteolysis; Calpains; Calpastatin; Fodrin breakdown; Global ischemia

Indexed keywords

CALPAIN; CALPASTATIN; FODRIN; NEUTRAL PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ISOLATION; ENZYME LOCALIZATION; ENZYME POLYMORPHISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; RAT;

ANIMALIA;

EID: 0031799137     PISSN: 10447393     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02815181     Document Type: Article

References (45)

1. Arai A., Kessler M., Lee K., and Lynch G. (1990) Calpain inhibitors improve the recovery of synaptic transmission from hypoxia in hippocampal slices. Brain Res. 532, 63-68.
2. Bartus R. T., Baker K. L., Heiser A. D., Sawyer S. D., Dean R. L., Elliott P. J., et al. (1994) Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage. J. Cereb. Blood Flow Metab. 14, 537-544.
3. Bartus R. T., Dean R. L., Cavanough K., Eveleth D., Carriero D. L., and Lynch G. (1995a) Time-related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain. J. Cereb. Blood Flow Metab. 15, 969-979.
4. Bartus R. T., Elliott P. J., Hayward N. J., Dean R. L., Harbeson S, Straub J. A., et al. (1995b) Calpain as a novel target for treating acute neurodegenerative disorders. Neurol. Res. 17, 249-258.
5. Blomgren K., Nilsson E., and Karlsson J.-O. (1989) Calpain and calpastatin levels in different organs of the rabbit. Comp. Biochem. Physiol. 93B, 403-407.
6. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
7. Chakrabarti A., Yoshida Y., Powers J., Singh I., Hogan E., and Banik N. (1988) Calcium-activated neutral proteinase in rat brain myelin and subcellular fractions. J. Neurosci. Res. 20, 351-358.
8. Croall D. E. and DeMartino G. N. (1991) Calcium-activated neutral protease (calpain) system: structure, function and regulation. Physiol. Rev. 71, 813-847.
9. Domańska-Janik K. and Zabłocka B. (1993) Protein kinase C as an early and sensitive marker of ischemia-induced progressive neuronal damage in gerbil hippocampus. Mol. Chem. Neuropathol. 20, 111-123.
10. Emori Y., Kawasaki H., Imajoh S., Imahori K., and Suzuki K. (1987) Endogenous inhibitor for calcium-dependent cysteine protease contains four internal repeats that could be responsible for its multiple reactive sites. Proc. Natl. Acad. Sci. 84, 3590-3594.
11. Goll D. E., Thompson V. F., Taylor R. G., and Zalewska T. (1992) Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? BioEssays 14, 549-556.
12. Gopalakrishna R. and Barsky S. H. (1986) Hydrophobic association of calpains with subcellular organelles. Compartmentalization of calpains and the endogenous inhibitor calpastatin in tissues. J. Biol. Chem. 261, 13,936-13,942.
13. Hata A., Ohno S., Akita Y., and Suzuki K. (1989) Tandemly reiterated negative enhancer-like elements regulate transcription of a human gene for the large subunit of calcium-dependent protease. J. Biol. Chem. 264, 6404-6411.
14. Hong S-CC, Goto Y., Lanzino G., Soleau S., Kassell N. F., and Lee K. S. (1994) Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 25, 663-669.
15. Inomata M., Hayashi, M., Nakamura M., Imahori K., and Kawashima S. (1983) Purification and characterization of a calcium-activated neutral proteases from rabbit skeletal muscle which requires calcium ions of μM concentration. J. Biochem. (Tokyo) 93, 291-294.
16. Inomata M., Hayashi M., Nakamura M., Saito Y., and Kawashima S. (1989) Properties of erythrocyte membrane binding and autolytic activation of calcium-activated neutral protease. J. Biol. Chem. 264, 18,838-18,843.
17. 2+ on binding of the calpains to calpastatin. J. Biol. Chem. 264, 17,888-17,896.
18. 4. Nature 227, 680-685.
19. Lee K., Frank S., Vanderklish P., Arai A., and Lynch G. (1991) Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc. Natl. Acad. Sci. USA 88, 7233-7237.
20. Li J., Grynspan F., Berman S., Nixon R., and Bursztajn S. (1996) Regional differences in gene expression for calcium activated neutral proteases (calpains) and their endogenous inhibitor calpastatin in mouse brain and spinal cord. J. Neurobiol. 30, 177-191.
21. Lowry O. H., Rosebrough M. J., Farr A. L., and Randall R. J. (1951) Protein measurement with Folin phenol reagent. J. Biol. Chem. 193, 265-275.
22. Maki M., Takano E., Mori H., Kannagi R., Murachi T., and Hatanaka M. (1987) Repetitive region of calpastatin is a functional unit of the poteinase inhibitor. Biochem. Biophys. Res. Commun. 143, 300-308.
23. Mellgren R. L. (1987) Calcium-dependent proteases: an enzyme system active at cellular membranes? FASEB. J. 1, 110-115.
24. Neumar R. W., Hagle S. M., DeGracia D. J., Krause G. S., and White B. C. (1996) Brain μ-calpain autolysis during global cerebral ischemia. J. Neurochem. 66, 421-424.
25. Nilsson E., Ostwald K., and Karlsson J. O. (1991) Changes in brain calpain activity as a result of in vitro ischemia and pH alterations. Mol. Chem. Neuropathol. 14, 99-111.
26. Ostwald K., Hagberg H., Andine P., and Karlsson J-O. (1993) Upregulation of calpain activity in neonatal rat brain after hypoxic-ischemia. Brain Res. 630, 289-294.
27. Ostwald K., Hayashi M., Nakamura M., and Kawashima S. (1994) Subcellular distribution of calpain and calpastatin immunoreactivity and fodrin proteolysis in rabbit hippocampus after hypoxia and glucocorticoid treatment. J. Neurochem. 63, 1069-1076.
28. Rami A. and Krieglstein J. (1993) Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res. 609, 67-70.
29. Roberts-Levis J., Savage M., Marcy V., Pinsker L., and Siman R. (1994) Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J. Neurosci. 16, 3934-3944.
30. Saido T. C., Nagao S., Shiramine M., Tsukaguchi M., Sorimachi H., Murofushi H., et al. (1992) Autolytic transition of μ-calpain upon activation as resolved by antibodies distinguishing between pre- and post-autolysis forms. J. Biochem (Tokyo) 111, 81-86.
31. Saido T. C., Suzuki H., Yamazaki H., Tanoue K., and Suzuki K. (1993a) In situ capture of μ-calpain activation in platelets. J. Biol. Chem. 268, 7422-7426.
32. Saido T. C., Yokota M., Nagao S., Yamaura I., Tani E., Tsuchiya T., et al. (1993b) Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 268, 25,239-25,243.
33. Saido T., Sorimachi H., and Suzuki K. (1994) Calpain: New perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8, 814-822.
34. Seubert P., Lee K., and Lynch G. (1989) Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res. 492, 366-370.
35. Sorimachi H., Toyama-Sorimachi N., Saido T. C., Kawasaki H., Sugita H., Miyasaka M., et al. (1993) Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J. Biol. Chem. 268, 10,593-10,605.
36. Suzuki K. and Ohno S. (1990) Calcium activated neutral protease: structure-function relationship and functional implications. Cell Struct. Funct. 15, 1-6.
37. Suzuki K., Imajoh S., Emori Y., Kawasaki H., Minami Y., and Ohno S. (1988) Regulation of activity of calcium activated neutral protease, in Enzyme Regulation, vol. 27 (Weber G., ed.), pp 155-169, Pergamon, London.
38. Takahashi K. (1990) Calpain substrate specificity, in Intracellular Calcium Dependent Proteolysis, pp. 55-74 CRC. Boca Raton, FL.
39. Takeuchi K., Saito K. -I., and Nixon R. (1992) Immunoassay and activity of calcium-activated neutral proteinase (mCANP): distribution in soluble and membrane-associated fractions in human and mouse brain. J. Neurochem. 58, 1526-1532.
40. Towbin H., Stachelin T., and Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354.
41. Tzigaret C., McIntosh T. K., Okiyama K., Jenkins W. L., and Prased M. R. (1993) Measurement of hippocampal levels of cellular second messengers following in situ freezing. J. Neurochem. 60, 827-834.
42. 2+-dependent proteinases. Biochim. Biophys. Acta 998, 236-250.
43. Zalewska T. (1996) Calpain as proposed target for neuroprotecrive treatment of brain ischemia. Folia Neuropathol. 3, 121-127.
44. Zalewska T., Kasai Y., and Kawashima S. (1989) Calcium-dependent proteolytic activity in hypoxic rat brain. Biomed. Biochim. Acta. 48, 166-169.
45. Zalewska T., Białynicka-Birula K., and Domańska-Janik K. (1996) Autophosphorylation as a possible mechanism of calcium/calmodulin-dependent protein kinase II inhibition during ischemia. Neurochem. Int. 28, 175-181.